Chronic Obstructive Pulmonary Disease — A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD
Citation(s)
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group, Dose Finding Study Evaluating the Safety and Efficacy of Infliximab Administration in Symptomatic Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)